Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway. - Wikidata - wikimedia - TriplyDB

Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.

Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.

http://www.wikidata.org/entity/Q35546017

about

Anti-inflammatory effects of propranolol in the temporomandibular joint of female rats and its contribution to antinociceptive action.Noncanonical regulation of insulin-mediated ERK activation by phosphoinositide 3-kinase γ.

P2860

Q47566881-544E1C64-AD25-408A-A1A9-58A27FD51EA2 Q47846769-1510C035-CDA8-4089-80B9-A95D4B698FCC

P2860

Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.

http://www.wikidata.org/entity/Q35546017

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Isoproterenol acts as a biased ...... ctivates the MAPK/ERK pathway.

@ast

Isoproterenol acts as a biased ...... ctivates the MAPK/ERK pathway.

@en

type

label

Isoproterenol acts as a biased ...... ctivates the MAPK/ERK pathway.

@ast

Isoproterenol acts as a biased ...... ctivates the MAPK/ERK pathway.

@en

prefLabel

Isoproterenol acts as a biased ...... ctivates the MAPK/ERK pathway.

@ast

Isoproterenol acts as a biased ...... ctivates the MAPK/ERK pathway.

@en

P1433

Q35546017-EDA2366D-BEC5-4D9B-89A7-0C184F9B5256

P1476

Q35546017-B8AE304F-4B3F-4E0B-9118-72548787B9E5

P2093

Q35546017-15869BFF-564B-416C-B0C3-0DC66D392C0A

Q35546017-3E783E73-2B94-491A-962A-96AD0D965D8E

Q35546017-47D8B15B-C11E-4920-86F6-07BE376CF17F

Q35546017-571538DE-E011-4CEF-88EC-21ED6394A306

Q35546017-6AE7E153-9C2C-4B1C-826F-33C23212A3A5

Q35546017-8B8E9B28-9AF5-4611-A889-DB697EB8FB20

Q35546017-A243F71C-629A-4278-9C22-A6EE40E74A61

Q35546017-C4ED9E60-65B9-40CC-96D6-F6EF5E62D9A2

Q35546017-C579FD59-9C38-473B-A26D-A3F8CC76A522

Q35546017-F77B1C26-97B7-400E-94E2-C62B4B3B8191

P2860

Q35546017-04F51806-FD95-4EB0-AE0E-EE3FBCF5D4A5

Q35546017-0B836387-95BE-485C-A633-2298AB64CA15

Q35546017-0C54298E-BB34-4464-A7C0-A2EF92B61B43

Q35546017-16571069-B472-4FCF-A086-2EF6E2D7AF64

Q35546017-18358706-9FEF-4689-9459-A53F1ED59B83

Q35546017-198A5DBD-27E8-4EC9-98D0-BD0C3F1C678D

Q35546017-1BA6EBAD-3E69-4D81-95C9-54B0BBAB7162

Q35546017-1E29CD42-C546-4C2D-A32E-A20739391FB7

Q35546017-29BEEDDC-E1D6-4127-8EA2-0688052A3A7D

Q35546017-29E8513C-0052-4D2B-A3CB-9942A76B895E

P304

Q35546017-92C149BC-B82B-457D-AAE0-2F9E0D9FD507

P31

Q35546017-9B5FCC34-50C9-4CEF-BA05-D54328766B3C

P356

Q35546017-25C115FA-8723-4F41-B222-230EEAE234C1

P407

Q35546017-30A1B8D8-BE82-4E0C-BFB6-BE696B66B136

P433

Q35546017-497EEF29-CA31-4773-AA57-713D61F7E31A

P478

Q35546017-B594E5DE-BC01-4E0E-9AF3-AB6030537B6A

P50

Q35546017-02DE2A08-AA35-4F11-B527-03CF92E90A06

P577

Q35546017-EBC7253C-BD2A-41B3-B987-4337E996CB51

P5875

Q35546017-B754B7EB-7669-4C8D-BED9-2A8ED0483E59

P698

Q35546017-75221A05-54B8-4CBA-B1A7-471F9D439727

P932

Q35546017-057051AD-C4A1-4D3E-8330-95C77BF3538F

P356

JOURNAL.PONE.0115701

P1433

P1476

Isoproterenol acts as a biased ...... activates the MAPK/ERK pathway

@en

P2093

Alan Kosaka

http://www.w3.org/2001/XMLSchema#string

Aleksander Baldys

http://www.w3.org/2001/XMLSchema#string

Anthony P D W Ford

http://www.w3.org/2001/XMLSchema#string

Bill Fitch

http://www.w3.org/2001/XMLSchema#string

Donald Button

http://www.w3.org/2001/XMLSchema#string

Hoangdung Ho

http://www.w3.org/2001/XMLSchema#string

John R Raymond

http://www.w3.org/2001/XMLSchema#string

Khanh Nguyen

http://www.w3.org/2001/XMLSchema#string

Marcos E Milla

http://www.w3.org/2001/XMLSchema#string

Paul J Dietrich

http://www.w3.org/2001/XMLSchema#string

P2860

Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Transduction of receptor signals by beta-arrestins

Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning

In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists

Binding, partial agonism, and potentiation of alpha(1)-adrenergic receptor function by benzodiazepines: A potential site of allosteric modulation

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification

Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50

Calcium signaling

Simultaneous determination of inositol and inositol phosphates in complex biological matrices: quantitative ion-exchange chromatography/tandem mass spectrometry.

P304

e0115701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0115701

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271332613

http://www.w3.org/2001/XMLSchema#string

P698

25606852

http://www.w3.org/2001/XMLSchema#string

P932

4301629

http://www.w3.org/2001/XMLSchema#string